drugset / Trial / NCT02518568

Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency Anaemia

NCT02518568 ↗

Phase 1 Terminated 29 enrolled Pierre Fabre Laboratories
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the pharmacokinetics of serum iron after a single oral administration of 160 mg (2 tablets of 80 mg) V0355 in women with iron deficiency anaemia.

Timeline

Start
2015-08
Primary completion
2016-05
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject V0355 Unknown 160 mg Oral